Utilidad clínica del Frontal Assessment Battery (FAB) en la detección de sintomatología disejecutiva en un grupo de personas con enfermedad de Parkinson y estudios superiores
DOI:
https://doi.org/10.47185/27113760.v2n2.61Resumen
N/A
Descargas
Citas
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Chaudhuri, K. R., & Weintraub, D. (2021). Parkinson disease-associated cognitive impairment. Nature Reviews Disease Primers, 7(1), 1-21. https://doi.or g/10.1038/s41572-021-00280-3
Ciccarelli, N., Colombo, B., Pepe, F., Magni, E., Antonietti, A., & Silveri, M. C. (2021). Cognitive reser ve: a multidimensional protective factor in Parkinson’s disease related cognitive impair ment. Aging, Neuropsychology, and Cognition, 1-16. DOI: 10.1080/13825585.2021.1892026
Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. F. A. B. (2000). The FAB: a frontal assessment battery at bedside. Neurology, 55(11), 1621-1626.
Kumaresan, M., & Khan, S. (2021). Spectrum of Non-Motor Symptoms in Parkinson's Disease. Cureus, 13(2): e13275. DOI: 10.7759/cu reus.13275
Marras, C., Tröster, A., Kulisevsky, J., & Stebbins, G. (2014). The Tools of the Trade: A State of the Art “How to Assess Cognition” in the Patient With Parkinson’s Disease. Movement Disorders, 29(5), 584-596. https://doi.or g/10.1002/mds.25874
Zaman, V., Shields, D. C., Shams, R., Drasites, K. P., Matzelle, D., Haque, A., & Banik, N. L. (2021). Cellular and molecular pathophysiology in the progression of Parkinson’s disease. Metabolic brain disease, 36, 815-827. https://doi.or g/10.1007/s11011-021-00689-5
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
